Drug Approval Processes Around the World: Focus on China

Impact of Clinical Pathways on Lung Cancer Management

Drug Development in the 21st Century

NICE: It Takes Two to Tango

What’s New from the 2016 ESMO Clinical Guidelines

Update to the “Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors”

National Comprehensive Cancer Network NSCLC Guideline Updates for 2016: Non-Small Cell Lung Cancer

Multifaceted Initiative Launches Aimed at Reducing Lung Cancer Deaths 25% by 2030

Increasing Adherence to CT Lung Cancer Screening Programs

COVID-19 and Lung Cancer

The Art and Science of Patient–Doctor Communication

Association of Race with Lung Cancer Risk Among Adults Undergoing Lung Cancer Screening